Behnam Sadeghi

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: MEDICAL ONCOLOGY. 2023;40(6):168
Pentoxifylline changes the balance of immune cell population in breast tumor-infiltrating lymphocytes
Kazemi MH; Shokrollahi Barough M; Momeni-Varposhti Z; Ghanavatinejad A; Zarehzadeh Mehrabadi A; Sadeghi B; Falak R
Article: CYTOTHERAPY. 2023;25(1):68-75
Immunomodulation by placenta-derived decidua stromal cells. Role of histocompatibility, accessory cells and freeze-thawing
Sadeghi B; Witkamp M; Schefberger D; Arbman A; Ringden O
Article: DERMATOLOGY. 2023;239(6):919-925
Safety and efficacy of autologous melanocyte/keratinocyte transplantation in patients with refractory stable vitiligo
Shahbazi A; Abedi-Valugerdi M; Kazemi S; Kochaksaraei S; Naseh MH; Aghdami N; Sadeghi B
Article: IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY. 2022;21(2):167-177
Decrease of Tumor-infiltrating Regulatory T Cells Using Pentoxifylline: An Ex Vivo Analysis in Triple-negative Breast Cancer Mouse Model
Kazemi MH; Barough MS; Ghanavatinejad A; Momeni-Varposhti Z; Khorrami S; Sadeghi B; Falak R
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:963445
Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review
Sadeghi B; Ringden O; Gustafsson B; Castegren M
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2021;25(22):10554-10564
Conquering the cytokine storm in COVID-19-induced ARDS using placenta-derived decidua stromal cells
Sadeghi B; Roshandel E; Pirsalehi A; Kazemi S; Sankanian G; Majidi M; Salimi M; Aghdami N; Sadrosadat H; Kochaksaraei SS; Alaeddini F; Ringden O; Hajifathali A
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2021;113(5):712-722
Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care
Ringden O; Remberger M; Torlen J; Finnbogadottir S; Svahn B-M; Sadeghi B
Article: INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 2020;153:317-326
Silk fibroin/sericin 3D sponges: The effect of sericin on structural and biological properties of fibroin
Siavashani AZ; Mohammadi J; Rottmar M; Senturk B; Nourmohammadi J; Sadeghi B; Huber L; Maniura-Weber K
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2020;111(4):591-594
Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells
Sadeghi B; Ersmark B; Moretti G; Mattsson J; Ringden O
Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2020;78:106042
The kidney injury caused by the onset of acute graft-versus-host disease is associated with down-regulation of αKlotho
Amin R; He R; Gupta D; Zheng W; Burmakin M; Mohammad DK; DePierre JW; Sadeghi B; Olauson H; Wernerson A; El-Andaloussi S; Hassan M; Abedi-Valugerdi M
Article: FRONTIERS IN IMMUNOLOGY. 2020;11:567210
Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
Ringden O; Gustafsson B; Sadeghi B
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1975-1983
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Ringden O; Boumendil A; Labopin M; Canaani J; Beelen D; Ehninger G; Niederwieser D; Finke J; Stelljes M; Gerbitz A; Ganser A; Kroeger N; Kantz L; Brecht A; Savani B; Sadeghi B; Mohty M; Nagler A
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(10):1965-1969
Long-Term Follow-Up of a Pilot Study Using Placenta-Derived Decidua Stromal Cells for Severe Acute Graft-versus-Host Disease
Sadeghi B; Remberger M; Gustafsson B; Winiarski J; Moretti G; Khoein B; Klingspor L; Westgren M; Mattsson J; Ringden O
Article: TRANSPLANTATION. 2019;103(6):1247-1252
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female Donor
Ringden O; Remberger M; Gustafsson B; Moretti G; Mattsson J; Winiarski J; Sadeghi B
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2685
Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells
Sadeghi B; Moretti G; Arnberg F; Samen E; Kohein B; Catar R; Kamhieh-Milz J; Geissler S; Moll G; Holmin S; Ringden O
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2018;107(4):478-485
Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation
Ringden O; Sadeghi B; Moretti G; Finnbogadottir S; Eriksson B; Mattsson J; Svahn B-M; Remberger M
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2018;7(4):325-332
Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease
Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
Article: JOURNAL OF INTERNAL MEDICINE. 2018;283(2):166-177
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
Ringden O; Labopi M; Sadeghi B; Mailhol A; Beelen D; Floisand Y; Ghavamzadeh A; Finke J; Ehninger G; Volin L; Socie G; Kroeger N; Stuhler G; Ganser A; Schmid C; Giebel S; Mohty M; Nagler A
Article: ACTA HAEMATOLOGICA. 2018;139(2):106-114
Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation
Aronsson-Kurttila W; Baygan A; Moretti G; Remberger M; Khoein B; Moll G; Sadeghi B; Ringden O
Article: PEDIATRIC TRANSPLANTATION. 2017;21(5)
Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life-threatening acute gastrointestinal graft-versus-host disease
Gustafsson B; Frisk P; Szakos A; Sadeghi B; Ringden O; Frost B-M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2017;176(3):431-439
Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT
Ringden O; Labopin M; Schmid C; Sadeghi B; Polge E; Tischer J; Ganser A; Michallet M; Kanz L; Schwerdtfeger R; Nagler A; Mohty M
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:795
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
Baygan A; Aronsson-Kurttila W; Moretti G; Tibert B; Dahllof G; Klingspor L; Gustafsson B; Khoein B; Moll G; Hausmann C; Svahn B-M; Westgren M; Remberger M; Sadeghi B; Ringden O
Article: INTERNATIONAL IMMUNOPHARMACOLOGY. 2016;40:41-49
Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice
Abedi-Valugerdi M; Wolfsberger J; Pillai PR; Zheng W; Sadeghi B; Zhao Y; Hassan M
Article: CYTOTHERAPY. 2015;17(12):1732-1745
Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo
Sadeghi B; Heshmati Y; Khoein B; Kaipe H; Uzunel M; Walfridsson J; Ringden O
Article: STEM CELLS AND DEVELOPMENT. 2015;24(19):2269-2279
Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua
Moll G; Ignatowicz L; Catar R; Luecht C; Sadeghi B; Hamad O; Jungebluth P; Dragun D; Schmidtchen A; Ringden O
Article: STEM CELLS AND DEVELOPMENT. 2015;24(12):1471-1482
Immunogenicity of Decidual Stromal Cells in an Epidermolysis Bullosa Patient and in Allogeneic Hematopoietic Stem Cell Transplantation Patients
Kaipe H; Carlson L-M; Erkers T; Nava S; Mollden P; Gustafsson B; Qian H; Li X; Hashimoto T; Sadeghi B; Alheim M; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2013;48(6):843-848
Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletion
Al Hashmi S; Sadeghi B; Hassan Z; Abedi-Valugerdi M; Lindskog M; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2013;48(2):284-293
Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target?
Sadeghi B; Al-Chaqmaqchi H; Al-Hashmi S; Brodin D; Hassan Z; Abedi-Valugerdi M; Moshfegh A; Hassan M
Article: PLOS ONE. 2013;8(4):e60367
The Role of Programmed Cell Death Ligand-1 (PD-L1/CD274) in the Development of Graft versus Host Disease
Al-Chaqmaqchi H; Sadeghi B; Abedi-Valugerdi M; Al-Hashmi S; Fares M; Kuiper R; Lundahl J; Hassan M; Moshfegh A
Article: PLOS ONE. 2012;7(1):e30897
Busulphan-Cyclophosphamide Cause Endothelial Injury, Remodeling of Resistance Arteries and Enhanced Expression of Endothelial Nitric Oxide Synthase
Al-Hashmi S; Boels PJM; Zadjali F; Sadeghi B; Sallstrom J; Hultenby K; Hassan Z; Arner A; Hassan M
Article: NATURE MEDICINE. 2011;17(12):1636-1640
Inhibition of proteasome deubiquitinating activity as a new cancer therapy.
D'Arcy P; Brnjic S; Olofsson MH; Fryknäs M; Lindsten K; De Cesare M; Perego P; Sadeghi B; Hassan M; Larsson R; Linder S
Article: INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. 2011;4(6):596-605
Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimen
Al-Hashmi S; Hassan Z; Sadeghi B; Rozell B; Hassan M
Article: CLINICAL AND DEVELOPMENTAL IMMUNOLOGY. 2010;2010:142943
Expansion and Activation Kinetics of Immune Cells during Early Phase of GVHD in Mouse Model Based on Chemotherapy Conditioning
Sadeghi B; Al-Hashmi S; Hassan Z; Rozell B; Concha H; Lundmark C; Gronvik K-O; Abedi-Valugerdi M; Hassan M
Article: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES. 2009;17(3):148-156
Preclinical and phase 1 clinical safety of Setarud (IMOD™), a novel immunomodulator
Khairandish P; Mohraz M; Farzamfar B; Abdollahi M; Shahhosseiny MH; Madani H; Sadeghi B; Heshmat R; Gharibdoust F; Khorram-Khorshid HR
Article: BONE MARROW TRANSPLANTATION. 2008;42(12):807-818
GVHD after chemotherapy conditioning in allogeneic transplanted mice
Sadeghi B; Aghdami N; Hassan Z; Forouzanfar M; Rozell B; Abedi-Valugerdi M; Hassan M
Article: BONE MARROW TRANSPLANTATION. 2008;41(10):895-904
The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model
Sadeghi B; Jansson M; Hassan Z; Mints M; Hagglund H; Abedi-Valugerdi M; Hassan M
Article: HUMAN REPRODUCTION. 2008;23(1):139-143
Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient
Mints M; Jansson M; Sadeghi B; Westgren M; Uzunel M; Hassan M; Palmblad J
Article: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES. 2008;16:31-34
Effect of ANGIPARS™, a new herbal drug on diabetic foot ulcer:: A phase 2 clinical study
Masoompour SM; Bagheri MH; Borhani HA; Novitsky YA; Sadeghi B; Gharibdoust F; Larijani B; Ranjbar OG
Article: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES. 2008;16(4):223-228
Studies on potential mutagenic and genotoxic activity of Setarud
Khorshid KHR; Novitsky YA; Abdollahi M; Shahhosseiny MH; Sadeghi B; Madani H; Rahimi R; Farzamfar B
Article: DARU-JOURNAL OF PHARMACEUTICAL SCIENCES. 2008;16:20-24
In vivo and in vitro genotoxicity studies of Semelil (ANGIPARS™)
Khorram KHR; Sadeghi B; Heshmat R; Abdollahi M; Salari P; Farzamfar B; Madani SH
Article: ACTA PAEDIATRICA. 2003;92(12):1394-1397
Effects of passive smoking on common respiratory symptoms in young children
Shiva F; Nasiri M; Sadeghi B; Padyab M
Article: CLINICAL BIOCHEMISTRY. 2001;34(4):309-315
Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease.
Haidari M; Javadi E; Sadeghi B; Hajilooi M; Ghanbili J
Visa fler

Alla övriga publikationer

Review: STEM CELLS. 2024;42(4):291-300
Placenta-Derived Decidua Stromal Cells: A New Frontier in the Therapy of Acute Graft-Versus-Host Disease
Ringden O; Sadeghi B
Review: FRONTIERS IN IMMUNOLOGY. 2023;14:1241068
Novel therapies for graft versus host disease with a focus on cell therapies
Zeiser R; Ringden O; Sadeghi B; Gonen-Yaacovi G; Segurado OG
Other: CLINICAL CASE REPORTS. 2022;10(5):e05851
Decidual stromal cell therapy for generalized lymphadenopathy as a special clinical manifestation of COVID-19 infection: A case report
Pirsalehi A; Soleimani M; Hajifathali A; Sadeghi B; Farhadihosseinabadi B; Akhlaghi SS; Roshandel E
Review: FRONTIERS IN IMMUNOLOGY. 2022;13:839844
Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
Ringden O; Moll G; Gustafsson B; Sadeghi B
Corrigendum: BIOMATERIALS SCIENCE. 2020;8(1):517
Silk based scaffolds with immunomodulatory capacity: anti-inflammatory effects of nicotinic acid (vol 8, pg 148, 2019)
Siavashani AZ; Mohammadi J; Maniura-Weber K; Senturk B; Nourmohammadi J; Sadeghi B; Huber L; Rottmar M
Published conference paper: BIOMATERIALS SCIENCE. 2019;8(1):148-162
Silk based scaffolds with immunomodulatory capacity: anti-inflammatory effects of nicotinic acid
Zakeri Siavashani A; Mohammadi J; Maniura-Weber K; Senturk B; Nourmohammadi J; Sadeghi B; Huber L; Rottmar M
Conference publication: TRANSPLANTATION. 2016;100(7):S438
Placenta-derived decidual stromal cells for treatment of severe acute graft-versus-host disease
Ringden O; Solders M; Baygan A; Remberger M; Erkers T; Nava S; Gustafsson B; Winiarski J; Westgren M; Sadeghi B; Kaipe H
Review: BONE MARROW TRANSPLANTATION. 2014;49(6):737-743
Stromal cells-are they really useful for GVHD?
Kaipe H; Erkers T; Sadeghi B; Ringden O
Book chapter: STEM CELL-DEPENDENT THERAPIES. 2013;p. 101-124
6 Mesenchymal stem cells for clinical/therapeutic interventions of graft-versus-host disease
Ringdén O; Sadeghi B
Book chapter: STEM CELL-DEPENDENT THERAPIES. 2013;p. 125-142
7 Mesenchymal stem cells for graft-versus-host disease in experimental animal models
Sadeghi B; Ringdén O
Editorial comment: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(11):1615-1617
Is Graft-versus-Leukemia More Effective Using Reduced-Intensity Conditioning Compared with Myeloablative Conditioning?
Ringden O; Sadeghi B
Thesis / dissertation: 2009
Immunobiology of graft versus host disease in chemotherapy based conditioning : new mouse model
Sadeghi, Behnam

Anställningar

Senior Forskare, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2022-

Examina och utbildning

Medicine Doktorsexamen, Institutionen för laboratoriemedicin, Karolinska Institutet, 2009

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI